EUVIMEDEUVIMED entdecken
Crossref

Development of Liposome Loaded Microneedle Patches for the Management of Rheumatoid Arthritis

Sanju Singh, Devendra Kumar Bhopte

International Journal of Drug Delivery Technology · 04.04.2026 · 16 (88s)

DOI: 10.25258/ijddt.16.89s.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.04.2026. Verfasst von Sanju Singh und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aims to develop anakinra and zaltoprofen-loaded liposomal microneedle patches for the management of rheumatoid arthritis. Anakinra is a recombinant interleukin-1 receptor antagonist that inhibits IL-1mediated inflammatory signaling, whereas zaltoprofen is a non-steroidal anti-inflammatory drug that helps relieve pain and inflammation. The combination of these agents is intended to investigate complementary antiinflammatory and analgesic effects. Liposomes are employed as drug carriers because their phospholipid bilayer structure enables the incorporation of different therapeutic agents and may help protect encapsulated drugs and modify their release. Microneedle patches provide a minimally invasive approach to overcome the stratum corneum barrier and facilitate drug delivery through the skin. The proposed formulation development involves the preparation and optimization of liposomes containing anakinra and zaltoprofen, followed by their incorporation into a suitable microneedle patch matrix. The liposomal formulations may be evaluated for vesicle size, polydispersity index, zeta potential, entrapment efficiency, morphology, and in vitro drug release. The prepared microneedle patches may be characterized for physical appearance, uniformity, mechanical strength, insertion ability, drug content, dissolution behavior, and drug-release kinetics. Further studies, including ex vivo skin permeation, stability testing, skin irritation assessment, and appropriate in vitro and in vivo pharmacological investigations, may be conducted to determine formulation performance, safety, and therapeutic potential. The developed anakinra and zaltoprofen liposome-loaded microneedle patches are expected to provide a novel drug delivery platform that combines cytokine inhibition with symptomatic anti-inflammatory and analgesic activity. This approach may improve administration convenience and facilitate transdermal delivery while potentially reducing some limitations associated with conventional dosage forms. However, the stability of anakinra during formulation, compatibility between the two drugs, preservation of biological activity, and the ability of the delivered drugs to achieve therapeutic effects in affected joints must be established experimentally. The findings of this study may provide a foundation for further research into combination drug delivery systems for rheumatoid arthritis. Keywords: Rheumatoid arthritis, anakinra, zaltoprofen, liposomes, microneedle patches, interleukin-1 receptor antagonist, transdermal drug delivery, anti-inflammatory activity.

Zitieren

APA

Singh, S., & Bhopte, D. K. (2026). Development of Liposome Loaded Microneedle Patches for the Management of Rheumatoid Arthritis. International Journal of Drug Delivery Technology, 16(88s). https://doi.org/10.25258/ijddt.16.89s.5

Vancouver

Singh S, Bhopte DK. Development of Liposome Loaded Microneedle Patches for the Management of Rheumatoid Arthritis. International Journal of Drug Delivery Technology. 2026;16(88s). doi:10.25258/ijddt.16.89s.5

BibTeX
@article{Singh2026,
  author = {Singh, Sanju and Bhopte, Devendra Kumar},
  title = {Development of Liposome Loaded Microneedle Patches for the Management of Rheumatoid Arthritis},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {88s},
  doi = {10.25258/ijddt.16.89s.5}
}
Kostenlos starten →